TrachAlarm: A novel, low-cost accessory to automatically detect and alert caregivers to tracheostomy tube decannulation

TrachAlarm：一种新颖的低成本配件，可自动检测气管切开插管并提醒护理人员

• 批准号: 10295975
• 负责人: VINAY M NADKARNI
• 金额: $ 80.79万
• 依托单位: INNOVATIONS UNLIMITED, LLC
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-09-17 至 2022-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10295975
• 关键词: Adverse event; Agreement; Algorithms; Caregivers; Cessation of life; Clinical; Computer software; Development; Device Designs; Device Safety; Devices; Effectiveness; Electronics; Ensure; Event; Feedback; Future; Health care facility; Healthcare; Home; Hospitals; Individual; Instruction; Intelligence; Intuition; Label; Licensing; Life; Location; Magnetism; Manufacturer Name; Medical Device; Modification; Movement; Neck; Patients; Performance; Phase; Population; Positioning Attribute; Power Sources; Procedures; Production; Regulation; Respiration; Risk; Running; Safety; Sales; Sensitivity and Specificity; Shipping; Small Business Innovation Research Grant; Specificity; Sterile coverings; Stomas; Surveys; System; Target Populations; Technology; Testing; Time; Trachea; Tracheostomy Tube; Tracheostomy procedure; Tube; Update; Ventilator; Visual; Wireless Technology; cost; demographic disparity; demographics; design; engineering design; improved; innovation; innovative technologies; large scale production; light weight; magnetic field; novel; operation; prevent; prototype; sensor; socioeconomic disparity; success; usability

Tracheostomy provides a critical, life-supporting function for over 6.5 million individuals in the U.S. with over 110,000 new procedures each year. The TrachAlarm is a novel, low-cost accessory to automatically detect and alert caregivers when a tracheostomy tube is accidentally removed from a patient. It provides a low-cost, accessible solution for tracheostomy patients and caregivers by utilizing magnetic sensing and smart alarms. The system integrates magnetic sensors in the patient dressing, and an alarm unit that easily connects to a tracheostomy flange and trach-tie. When the dressing is placed on the patient’s neck, magnetic sensors automatically align (around the periphery of the stoma) with the trachea insertion location. The alarm unit includes circuitry to detect the magnetic field. If the tube is moved away from the trachea, the alarm unit moves along with it, removing the detected magnetic field, creating an audible and visual alarm for the caregiver. Significant innovations distinguish the TrachAlarm from other market technologies. First, existing sensors and alarms are only available on ventilators that may be connected, but not for patients not requiring ventilators. Second, magnetic field technology provides a low-cost, low-burden device, easy for caregivers to use. These features will greatly improve technology accessibility to wide ranging demographics and socioeconomic disparate populations. Finally, accurate and automated alarms provide a significant benefit to patients by improving safety and preventing adverse events with overall burden to caregivers reduced. Phase II will expand upon successful Phase I prototype results to launch a commercially and clinically deployable TrachAlarm. The project is strategically positioned with four main objectives over a two-year period with specific tasks and success milestones. Aim 1 will use Phase I results to optimize device components, system packaging and alarm delivery. This includes finalizing all electronic components, device form factor, and developing all system packaging, user guides, and labeling for shipping and use. This task will enhance device safety and effectiveness by extending the on-device alarm to wireless mobile alarming. All modifications and additions will be technically verified by formal test cases. Aim 2 will target algorithmic enhancements to the alarming strategy to optimize both sensitivity and specificity. While the device requires 100% sensitivity, it is critical high specificity is also achieved to ensure users respond to the alarm when it occurs. Aim 3 will transition all engineering designs to formal manufacturing and quality procedures. This will include scaling the design for large scale production, minimizing costs, supplier assessments, and assembly instructions. A pre-production run of devices using the full-scale manufacturing procedures will be tested as per all required input specifications, medical device standards, and quality regulations. Finally, Aim 4 will complete a final update to any device design or manufacturing procedures and produce first article devices. These devices will be implemented in a large- scale field usability study to determine performance, effectiveness, and safety in the target user population.

气管切开术为美国超过650万患者提供了重要的生命支持功能